Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Neuroscience Letters|September 10, 2010
Variations of the CAG trinucleotide repeat in DNA polymerase γ (POLG1) is associated with Parkinson's disease in SwedenAnna Anvret, Marie Westerlund, Olof Sydow, et al.Clinical Neuropharmacology|February 8, 2011
A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusionJerker Westin, Dag Nyholm, Sven Pålhagen, et al.Neuroscience Letters|July 12, 2011
Genetic studies of the protein kinase AKT1 in Parkinson's diseaseCaroline Ran, Marie Westerlund, Anna Anvret, et al.IEEE Journal of Biomedical and Health Informatics|August 19, 2015
Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's DiseaseMevludin Memedi, Dag Nyholm, Anders Johansson, et al.BMC Neurology|September 6, 2012
CMV-associated encephalitis and antineuronal autoantibodies--a case reportXinling Xu, Peter Bergman, Thomas Willows, et al.The Open Neurology Journal|April 13, 2012
Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson's DiseaseAnna Anvret, Caroline Ran, Marie Westerlund, et al.The Open Neurology Journal|May 3, 2011
DJ-1 Mutations are Rare in a Swedish Parkinson CohortAnna Anvret, Jeff G Blackinton, Marie Westerlund, et al.Journal of Parkinson'S Disease|October 7, 2017
Initiation of Levodopa-Carbidopa Intestinal Gel Infusion Using Telemedicine (Video Communication System) Facilitates Efficient and Well-Accepted Home Titration in Patients with Advanced Parkinson's DiseaseThomas Willows, Nil Dizdar, Dag Nyholm, et al.Parkinson'S Disease|May 26, 2017
Genetic Variations and mRNA Expression of NRF2 in Parkinson's DiseaseCaroline Ran, Karin Wirdefeldt, Lovisa Brodin, et al.Journal of Neurology|July 3, 2020
Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson's diseasePeter Hagell, Arja Höglund, Carina Hellqvist, et al.Pageof 2